Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Cyril Quivoron

A small molecule inhibitor of mutant IDH2 rescues cardiomyopathy in a D-2-hydroxyglutaric aciduria type II mouse model.

scientific article published on 28 July 2016

AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations.

scientific article published on 13 February 2017

B-cell tumor development in -deficient mice

article

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

scientific article published on 16 July 2018

Discovery of AG-120 (Ivosidenib): A First-in-Class Mutant IDH1 Inhibitor for the Treatment of IDH1 Mutant Cancers.

scientific article published on 19 January 2018

Isocitrate dehydrogenase (IDH)2 R140Q mutation induces myeloid and lymphoid neoplasms in mice

scientific article published on 14 January 2014

Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations

scientific article published on 26 February 2018

Quantitation of isocitrate dehydrogenase (IDH)-induced D and L enantiomers of 2-hydroxyglutaric acid in biological fluids by a fully validated liquid tandem mass spectrometry method, suitable for clinical applications

scientific article published on 23 April 2016

Serum 2-hydroxyglutarate production in IDH1- and IDH2-mutated de novo acute myeloid leukemia: a study by the Acute Leukemia French Association group.

scientific article

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis

scientific journal article

TET2, a tumor suppressor in hematological disorders.

scientific article published on 03 January 2012

Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation

scientific article

[In cauda venenum or the importance of TET(2)]

scientific article published on 23 December 2011